Cargando…
Direct Oral Anticoagulants Concentration Testing in Clinical Practice for High-Risk Patients with AF
Autores principales: | Pukite, K, Urtane, I, Pupkevica, I, Cernevska, I, Boicuka, O, Meisters, J, Straupmane, D, Strelnieks, A, Lejnieks, A, Kalejs, O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312530/ https://www.ncbi.nlm.nih.gov/pubmed/32612694 http://dx.doi.org/10.15420/ecr.2020.15.1.PO11 |
Ejemplares similares
-
Comorbidity Differentiation and Risk Stratification in the Elderly Patient with Polypharmacy: A Prospective Primary Care Registry on Oral Anticoagulation Therapy
por: van Vugt, S, et al.
Publicado: (2020) -
Evaluating the Potential Effect of L-carnitine on the Prevention of AF Following Coronary Artery Bypass Graft Surgery: A Randomised Clinical Trial
por: Dastan, F
Publicado: (2020) -
Stability of Direct Oral Anticoagulants Concentrations in Blood Samples for Accessibility Expansion of Chromogenic Assays
por: Gavrilova, Anna, et al.
Publicado: (2023) -
The Role of Isocitrate Dehydrogenases in Direct Reprogramming to Cardiomyocytes
por: Ishida, Tomoaki, et al.
Publicado: (2021) -
Oral Presentation Award Winner: β3 Adrenergic Receptors in the Sinoatrial Node for Heart Rate Regulation
por: Nakao, Shu, et al.
Publicado: (2021)